naltrexone has been researched along with Learning Disabilities in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golaghaei, A; Hosseini, SM; Mohammadi, S; Naderi, N; Nassireslami, E; Pourbadie, HG; Rahimzadegan, M | 1 |
| Carey, AN; Dunton, O; Lyons, AM; McLaughlin, JP; Shay, CF | 1 |
| Hiramatsu, M; Watanabe, E | 1 |
| Grau, JW; Hook, MA; Huie, JR | 1 |
| Itoh, J; Kameyama, T; Kobayashi, T; Shinkai, N; Ukai, M | 1 |
| Becker, A; Grecksch, G; Höllt, V; Schroeder, H | 1 |
| Hiramatsu, M; Inoue, K | 1 |
7 other study(ies) available for naltrexone and Learning Disabilities
| Article | Year |
|---|---|
Neuroprotective effects of lipopolysaccharide and naltrexone co‑preconditioning in the photothrombotic model of unilateral selective hippocampal ischemia in rat.
Topics: Animals; Avoidance Learning; Brain Ischemia; Disease Models, Animal; Functional Laterality; Hippocampus; Injections, Intraventricular; Ischemic Preconditioning; Learning Disabilities; Lipopolysaccharides; Male; Maze Learning; Naltrexone; Neuroprotective Agents; Photic Stimulation; Random Allocation; Rats; Rats, Wistar; Reaction Time; Treatment Outcome | 2019 |
Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Behavior, Animal; Enkephalins; Gene Expression Regulation; Immobility Response, Tonic; Learning Disabilities; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Naltrexone; Narcotic Antagonists; Protein Precursors; Receptors, Opioid, kappa; Recognition, Psychology; Stress, Psychological; Swimming; Time Factors | 2009 |
Dynorphin A (2-13) improves mecamylamine-induced learning impairment accompanied by reversal of reductions in acetylcholine release in rats.
Topics: Acetylcholine; Animals; Dynorphins; Functional Laterality; Hippocampus; Injections, Intraventricular; Learning; Learning Disabilities; Male; Mecamylamine; Microdialysis; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley | 2006 |
Peripheral inflammation undermines the plasticity of the isolated spinal cord.
Topics: Analysis of Variance; Animals; Capsaicin; Conditioning, Psychological; Dose-Response Relationship, Drug; Electric Stimulation; Inflammation; Learning Disabilities; Male; Naltrexone; Narcotic Antagonists; Neuronal Plasticity; Pain Threshold; Random Allocation; Rats; Rats, Sprague-Dawley; Sensory System Agents; Spinal Cord Injuries; Time Factors; Touch | 2008 |
Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice.
Topics: Analgesics, Opioid; Animals; Dynorphins; Injections, Intraventricular; Learning; Learning Disabilities; Male; Memory; Memory Disorders; Memory, Short-Term; Mice; Mice, Inbred Strains; Muscarinic Antagonists; Naltrexone; Narcotic Antagonists; Peptide Fragments; Pirenzepine; Receptors, Opioid, kappa; Scopolamine | 1997 |
Involvement of delta-opioid receptors in pentylenetetrazol kindling development and kindling-related processes in rats.
Topics: Animals; Convulsants; Drug Interactions; Glutamic Acid; Injections, Intraventricular; Kindling, Neurologic; Learning Disabilities; Male; Naltrexone; Narcotic Antagonists; Pentylenetetrazole; Rats; Rats, Wistar; Receptors, Opioid, delta; Seizures; Time Factors | 1999 |
Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory.
Topics: Analgesics, Opioid; Animals; Avoidance Learning; Disease Models, Animal; Dizocilpine Maleate; Learning Disabilities; Male; Maze Learning; Memory Disorders; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Nociceptin; Opioid Peptides; Psychomotor Performance; Rats; Scopolamine | 2000 |